NOA THERAPEUTICS
LIVE

Serial Number

99054107

Owner

Noa Therapeutics

Attorney

Stacy J. Grossman

Filing Date

Feb 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOA THERAPEUTICS Trademark

Serial Number: 99054107

NOA THERAPEUTICS is a trademark filed by Noa Therapeutics on February 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Noa Therapeutics (2 trademarks)

101 College St.
Toronto, ON M5G 1L7

Entity Type: 03

Trademark Details

Filing Date

February 24, 2025

Registration Date

Not Registered

Goods & Services

pharmaceutical and veterinary preparations for the treatment of inflammatory barrier diseases, systemic inflammatory diseases, inflammatory skin diseases; cardiovascular pharmaceuticals; gastrointestinal pharmaceuticals; central nervous system pharmaceuticals; ocular and ophthalmic pharmaceuticals; nutraceuticals for the treatment of immune and inflammatory barrier diseases; medicated skin care preparations, namely, cosmeceuticals for the treatment of chronic inflammatory skin disease

Medical research in the field of immune diseases; pharmaceutical research and development

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 27, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 27, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jan 27, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 24, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 24, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 29, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 24, 2025 MAFR
NEW APPLICATION ENTERED
Feb 24, 2025 NWAP